Journal of Neuroimmunology, 38 (1992) 285-287 © 1992 Elsevier Science Publishers B.V. All rights reserved 0165-5728 /92/$05.00 Author Index (V ol. 38) Allard, M., see Lecron, J.-C. (38) 1 Gausas, J., see Koh, C.-S. (38) 85 Arnason, B.G.W., see Jensen, M.A. (38) 255 Gavish, M., see Bessler, H. (38) 19 Glaser, R., see Kusnecov, A.V. (38) 129 Baker, D., see O’Neill, J.K. (38) 53 Gombert, J., see Lecron, J.-C. (38) 1 Bannon, M.J., see Loeffler, D.A. (38) 45 Goube de Laforest, P., see Lecron, J.-C. (38) 1 Barnum, S.R., Jones, J.L. and Benveniste, E.N. Grota, L.J., see Kusnecov, A.V. (38) 129 Interferon-gamma regulation of C3 gene expression in Haahr, S. human astroglioma cells (38) 275 Second International Symposium on Retrovirus in Multi- Batticane, N., see Morale, M.C. (38) 185 ple Sclerosis and Related Diseases. 26-28 August 1991, Benveniste, E.N., see Barnum, S.R. (38) 275 The Old Dok, Copenhagen, Denmark (38) 163 Bessler, H., Weizman, R., Gavish, M., Notti, I. and Djaldetti, Hashim, G.A., see Chou, Y.K. (38) 105 M. Heijnen, C.J., see Kooijman, R. (38) 95 Immunomodulatory effect of peripheral benzodiazepine Houlgatte, R., see Jabbour, W. (38) 199 receptor ligands on human mononuclear cells (38) 19 Betti, F., see Paik, S.H. (38) 35 Jabbour, W., Pouplard-Barthelaix, A., Houlgatte, R. and Bonneau, R.H., see Kusnecov, A.V. (38) 129 Emile, J. Bourdette, D.N., see Chou, Y.K. (38) 105 Abnormal expression of actin in lymphocytes of Brickman, C.M., see Loeffler, D.A. (38) 45 Alzheimer’s disease and Down’s syndrome patients (38) Brinkman, A., see Kooijman, R. (38) 95 199 Briick, W., Briick, Y. and Friede, R.L. Jaffee, B.D., see O’Neill, J.K. (38) 53 TNF-a suppresses CR3-mediated myelin removal by Jensen, M.A., Arnason, B.G.W., Toscas, A. and Noronha, A. macrophages (38) 9 Preferential increase of IL-2R* CD4* T cells and Briick, Y., see Briick, W. (38) 9 CD45RB~ CD4* T cells in the central nervous system in experimental allergic encephalomyelitis (38) 255 Camargo, A.C.M., see Paik, S.H. (38) 35 Jones, J.L., see Barnum, S.R. (38) 275 Cassin, B., see Loeffler, D.A. (38) 45 Kakimoto, K., see Yamada, M. (38) 263 Castagna, A., see Froldi, M. (38)-155 Kapatos, G., see Loeffler, D.A. (38) 45 Chou, Y.K., Bourdette, D.N., Offner, H., Whitham, R., Wang, Kapp, J.A., see Van der Veen, R.C. (38) 139 R.-Y., Hashim, G.A. and Vandenbark, A.A. Kennedy, M.K., see McRae, B.L. (38) 229 Frequency of T cells specific for myelin basic protein and Koh, C.-S., Gausas, J. and Paterson, P.Y. myelin proteolipid protein in blood and cerebrospinal fluid Concordance and localization of maximal vascular perme- in multiple sclerosis (38) 105 ability change and fibrin deposition in the central neuraxis Cioni, M., see Morale, M.C. (38) 185 of Lewis rats with cell-transferred experimental allergic Conti-Tronconi, B.M., see McLane, K.E. (38) 115 encephalomyelitis (38) 85 Kooijman, R., Willems, M., Rijkers, G.T., Brinkman, A., Dal Canto, M.C., see McRae, B.L. (38) 229 Van Buul-Offers, S.C., Heijnen, C.J. and Zegers, B.J.M. Davison, A.N., see O’Neill, J.K. (38) 53 Effects of insulin-like growth factors and growth hormone De Oliveira, E.S., see Paik, S.H. (38) 35 on the in vitro proliferation of T lymphocytes (38) 95 Djaldetti, M., see Bessler, H. (38) 19 KuKuruga, M.A., see Loeffler, D.A. (38) 45 Drachman, D.B., see McIntosh, K.R. (38) 75 Kusnecov, A.V., Grota, L.J., Schmidt, $.G., Bonneau, R.H., Sheridan, J.F., Glaser, R. and Moynihan, J.A. Emile, J., see Jabbour, W. (38) 199 Decreased herpes simplex viral immunity and enhanced pathogenesis following stressor administration in mice (38) Fredrikson, S., see Link, H. (38) 63 129 Friede, R.L., see Briick, W. (38) 9 Froldi, M., Castagna, A., Parma, M., Piona, A., Tedeschi, A., Lazzarin, A., see Froldi, M. (38) 155 Miadonna, A., Lorini, M., Nobile Orazio, E. and Lazzarin, Lecron, J.-C., Minault, M., Allard, M., Goube de Laforest, P., A. Gombert, J. and Simonnet, G. Mediator release in cerebrospinal fluid of human immun- Modulation of human lymphocyte proliferation by odeficiency virus-positive patients with central nervous FLFQPQRFamide, a FMRFamide-like peptide with anti- system involvement (38) 155 opiate properties (38) 1 286 LeWitt, P.A., see Loeffler, D.A. (38) 45 Onoue, K., see Yamada, M. (38) 263 Lindstrom, J.M., see McLane, K.E. (38) 115 Ottaway, C.A. Link, H., Sun, J.-B., Wang, Z., Xu, Z., Love, A., Fredrikson, Receptors for vasoactive intestinal peptide on murine lym- S. and Olsson, T. phocytes turn over rapidly (38) 241 Virus-reactive and autoreactive T cells are accumulated in cerebrospinal fluid in multiple sclerosis (38) 63 Paik, S.H., Betti, F., Camargo, A.C.M. and De Oliveira, E.S. Loeffler, D.A., Brickman, C.M., LeWitt, P.A., Bannon, M.J., Presence of endo-oligopeptidase (EC 3.4.22.19), a putative KuKuruga, M.A., Cassin, B. and Kapatos, G. neuropeptide-metabolizing endopeptidase in cells of the Non-specific binding of normal human IgG, including immune system (38) 35 F(ab’), and Fc fragments, to embryonic rat brain neurons Parma, M., see Froldi, M. (38) 155 and human cortex synaptosomes (38) 45 Paterson, P.Y., see Koh, C.-S. (38) 85 Lorini, M., see Froldi, M. (38) 155 Picha, K.S., see McRae, B.L. (38) 229 Léve, A., see Link, H. (38) 63 Piona, A., see Froldi, M. (38) 155 Luecken, L.J. and Lysle, D.T. Pouplard-Barthelaix, A., see Jabbour, W. (38) 199 Evidence for the involvement of B-adrenergic receptors in conditioned immunomodulation (38) 209 Lysle, D.T., see Luecken, L.J. (38) 209 Reingold, S.C. A Symposium on Multiple Sclerosis, dedicated to B.H. Waksman. Presented at the Third International Congress Maggon, K.K., see O’Neill, J.K. (38) 53 of Neuroimmunology, October 27—November 1, 1991, Marchetti, B., see Morale, M.C. (38) 185 Jerusalem, Israel (38) 175 McIntosh, K.R. and Drachman, D.B. Rijkers, G.T., see Kooijman, R. (38) 95 Tolerance to acetylcholine receptor induced by AChR- coupled syngeneic cells (38) 75 McLane, K.E., Wu, X., Lindstrom, J.M. and Conti-Tronconi, Schabet, M., see Wiethdlter, H. (38) 221 B.M. Schmidt, $.G., see Kusnecov, A.V. (38) 129 Epitope mapping of polyclonal and monoclonal antibodies Sharief, M.K. and Thompson, E.J. against two a-bungarotoxin-binding a subunits from neu- In vivo relationship of tumor necrosis factor-a to blood- ronal nicotinic receptors (38) 115 brain barrier damage in patients with active multiple scle- McRae, B.L., Kennedy, M.K., Tan, L.J., Dal Canto, M.C., rosis (38) 27 Picha, K.S. and Miller, S.D. Sheridan, J.F., see Kusnecov, A.V. (38) 129 Induction of active and adoptive relapsing experimental Shinbori, T., see Yamada, M. (38) 263 autoimmune encephalomyelitis (EAE) using an encephali- Simonnet, G., see Lecron, J.-C. (38) 1 togenic epitope of proteolipid protein (38) 229 Sommer, N., see Wiethdlter, H. (38) 221 Melms, A., see Wiethdlter, H. (38) 221 Stevens, A., see Wiethdlter, H. (38) 221 Miadonna, A., see Froldi, M. (38) 155 Sun, J.-B., see Link, H. (38) 63 Miller, S.D., see McRae, B.L. (38) 229 Minault, M., see Lecron, J.-C. (38) 1 Tan, L.J., see McRae, B.L. (38) 229 Moore, P.M. Tedeschi, A., see Froldi, M. (38) 155 Evidence for bound antineuronal antibodies in brains of Thompson, E.J., see Sharief, M.K. (38) 27 NZB/W mice (38) 147 Toscas, A., see Jensen, M.A. (38) 255 Morale, M.C., Batticane, N., Cioni, M. and Marchetti, B. Trotter, J.L., see Van der Veen, R.C. (38) 139 Upregulation of lymphocyte B-adrenergic receptor in Turk, J.L., see O’Neill, J.K. (38) 53 Down’s syndrome: a biological marker of a neuroimmune deficit (38) 185 Moynihan, J.A., see Kusnecov, A.V. (38) 129 Ushio, Y., see Yamada, M. (38) 263 Nobile Orazio, E., see Froldi, M. (38) 155 Van Buul-Offers, S.C., see Kooijman, R. (38) 95 Noronha, A., see Jensen, M.A. (38) 255 Vandenbark, A.A., see Chou, Y.K. (38) 105 Notti, I., see Bessler, H. (38) 19 Van der Veen, R.C., Trotter, J.L. and Kapp, J.A. Immune processing of proteolipid protein by subsets of antigen-presenting spleen cells (38) 139 Offner, H., see Chou, Y.K. (38) 105 Olsson, T., see Link, H. (38) 63 O’Neill, J.K., Baker, D., Davison, A.N., Maggon, K.K., Jaffee, Wang, R.-Y., see Chou, Y.K. (38) 105 B.D. and Turk, J.L. Wang, Z., see Link, H. (38) 63 Therapy of chronic relapsing experimental allergic en- Weizman, R., see Bessler, H. (38) 19 cephalomyelitis and the role of the blood-brain barrier: Weller, M., see Wiethdlter, H. (38) 221 elucidation by the action of Brequinar sodium (38) 53 Whitham, R., see Chou, Y.K. (38) 105 287 Wiethdlter, H., Schabet, M., Stevens, A., Melms, A., Sommer, Yamada, M., Kakimoto, K., Shinbori, T., Ushio, Y. and Onoue, N. and Weller, M. K. Influence of gangliosides on experimental allergic neuritis Accessory function of human glioma cells for the induction (38) 221 of CD3-mediated T cell proliferation: a potential role of Willems, M., see Kooijman, R. (38) 95 glial cells in T cell activation in the central nervous system Wu, X., see McLane, K.E. (38) 115 (38) 263 Xu, Z., see Link, H. (38) 63 Zegers, B.J.M., see Kooijman, R. (38) 95 Journal of Neuroimmunology, 38 (1992) 288-292 © 1992 Elsevier Science Publishers B.V. All rights reserved 0165-/5927 /2$058.0 0 Subject Index (Vol. 38) Accessory function Avian nervous system Glioma cells; T cell proliferation (Yamada, M. (38) 263) a-Bungarotoxin-binding protein; Nicotinic acetylcholine re- ceptor; Synthetic peptides; Recombinant fusion protein; Epi- Actin tope mapping (McLane, K.E. (38) 115) Alzheimer’s disease; Down’s syndrome; Lymphocyte (Jab- bour, W. (38) 199) Blood—brain barrier Cerebrospinal fluid; Tumor necrosis factor-a; Multiple sclero- B-Adrenergic receptor sis (Sharief, M.K. (38) 27) Down’s syndrome; Immune depression; Flow cytometry; Cell sorter; Lymphocyte subset; T-helper; T-suppressor; Natural Brequinar sodium; Cyclophosphamide; Cyclosporin A; Exper- killer (Morale, M.C. (38) 185) imental allergic encephalomyelitis; Immunosuppression (O’Neill, J.K. (38) 53) Immunomodulation; Conditioned aversive stimulus (Luecken, L.J. (38) 209) Cell-transferred experimental allergic encephalomyelitis; Fib- rin deposit (Koh, C.-S. (38) 85) Alzheimer’s disease Down’s syndrome; Lymphocyte; Actin (Jabbour, W. (38) 199) Brain elution Antibody Neuronal systemic lupus erythematosus; Antibody (Moore, Neuronal systemic lupus erythematosus; Brain elution (Moore, P.M. (38) 147) P.M. (38) 147) Brequinar sodium Experimental allergic neuritis; Ganglioside; Guillain-Barré Blood-brain barrier; Cyclophosphamide; Cyclosporin A; Ex- syndrome (Wiethdlter, H. (38) 221) perimental allergic encephalomyelitis; Immunosuppression (O’Neill, J.K. (38) 53) Antigen-coupled syngeneic cell Myasthenia gravis; Immunological tolerance (McIntosh, K.R. a -Bungarotoxin-binding protein (38) 75) Nicotinic acetylcholine receptor; Synthetic peptides; Recom- binant fusion protein; Avian nervous system; Epitope map- Antigen-presenting cell ping (McLane, K.E. (38) 115) Proteolipid protein; Immune processing; T cell clones (Van der Veen, R.C. (38) 139) Cell sorter Down’s syndrome; B-Adrenergic receptor; Immune depres- Anti-neuronal antibodies sion; Flow cytometry; Lymphocyte subset; T-helper; T-sup- Immunoglobulin; Synaptosome (Loeffler, D.A. (38) 45) pressor; Natural killer (Morale, M.C. (38) 185) Anti-opiate peptide Cell-transferred experimental allergic encephalomyelitis F8Fa; T lymphocyte; Monocyte (Lecron, J.-C. (38) 1) Blood-brain barrier; Fibrin deposit (Koh, C.-S. (38) 85) Astrocyte Complement; Interferon-y; Astroglioma; C3 protein (Barnum, Central nervous system S.R. (38) 275) Experimental allergic encephalomyelitis; Leukocyte common antigen; Interleukin-2 receptor; Flow cytometry; Delayed-type Astroglioma hypersensitivity (Jensen, M.A. (38) 255) Astrocyte; Complement; Interferon-y; C3 protein (Barnum, S.R. (38) 275) Cerebrospinal fluid Tumor necrosis factor-a; Multiple sclerosis; Blood—brain bar- Autoimmunity rier (Sharief, M.K. (38) 27) Multiple sclerosis; Retrovirus; Demyelination; Tropical spas- tic paraparesis; Myelopathy; (Conference abstracts) (Haahr, S. Human immunodeficiency virus; Leukotriene B, (Froldi, M. (38) 163) (38) 155) Compartmental kinetics Enkephalin Vasoactive intestinal peptide (VIP); VIP receptor; Lympho- Endopeptidase 22.19; Neuropeptide-metabolizing endopepti- cyte; VIP receptor turnover; Homologous regulation (Otta- dase; Leukocyte; Neuroimmunomodulation (Paik, S.H. (38) way, C.A. (38) 241) 35) Complement Epitope mapping Astrocyte; Interferon-y; Astroglioma; C3 protein (Barnum, a-Bungarotoxin-binding protein; Nicotinic acetylcholine re- S.R. (38) 275) ceptor; Synthetic peptides; Recombinant fusion protein; Avian nervous system (McLane, K.E. (38) 115) Complement receptor type 3 Myelin phagocytosis; Macrophage; Tumor necrosis factor al- Experimental allergic encephalomyelitis pha (TNF-a) (Briick, W. (38) 9) Blood-brain barrier; Brequinar sodium; Cyclophosphamide; Cyclosporin A; Immunosuppression (O’Neill, J.K. (38) 53) Conditioned aversive stimulus B-Adrenergic receptor; Immunomodulation (Luecken, L.J. Leukocyte common antigen; Interleukin-2 receptor; Flow cy- (38) 209) tometry; Central nervous system; Delayed-type hypersensitiv- ity (Jensen, M.A. (38) 255) C3 protein Astrocyte; Complement; Interferon-y; Astroglioma (Barnum, Experimental allergic neuritis Ganglioside; Antibody; Guillain-Barré syndrome (Wiethdlter, S.R. (38) 275) H. (38) 221) Cyclophosphamide Experimental autoimmune encephalomyelitis Blood-brain barrier; Brequinar sodium; Cyclosporin A; Ex- Proteolipid protein; SJL/J mice; Encephalitogenic peptide perimental allergic encephalomyelitis; Immunosuppression (McRae, B.L. (38) 229) (O'Neill, J.K. (38) 53) F8Fa Cyclosporin A Anti-opiate peptide; T lymphocyte; Monocyte (Lecron, J.-C. Blood-brain barrier; Brequinar sodium; Cyclophosphamide; (38) 1) Experimental allergic encephalomyelitis; Immunosuppression (O’Neill, J.K. (38) 53) Fibrin deposit Cell-transferred experimental allergic encephalomyelitis; Delayed-type hypersensitivity Blood-brain barrier (Koh, C.-S. (38) 85) Experimental allergic encephalomyelitis; Leukocyte common antigen; Interleukin-2 receptor; Flow cytometry; Central ner- Flow cytometry vous system (Jensen, M.A. (38) 255) Down’s syndrome; B-Adrenergic receptor; Immune depres- sion; Cell sorter; Lymphocyte subset; T-helper; T-suppressor; Demyelination Natural killer (Morale, M.C. (38) 185) Multiple sclerosis; Retrovirus; Autoimmunity; Tropical spastic paraparesis; Myelopathy; (Conference abstracts) (Haahr, S. Experimental allergic encephalomyelitis; Leukocyte common (38) 163) antigen; Interleukin-2 receptor; Central nervous system; De- layed-type hypersensitivity (Jensen, M.A. (38) 255) Down’s syndrome B-Adrenergic receptor; Immune depression; Flow cytometry; Ganglioside Cell sorter; Lymphocyte subset; T-helper; T-suppressor; Natu- Experimental allergic neuritis; Antibody; Guillain-Barré syn- ral killer (Morale, M.C. (38) 185) drome (Wiethdlter, H. (38) 221) Alzheimer’s disease; Lymphocyte; Actin (Jabbour, W. (38) Glioma cells 199) Accessory function; T cell proliferation (Yamada, M. (38) 263) Encephalitogenic peptide Growth hormone Experimental autoimmune encephalomyelitis; Proteolipid Insulin-like growth factor; IGF-binding protein; Proliferation; protein; SJL/J mice (McRae, B.L. (38) 229) T-Lymphocyte; Mitogen (Kooijman, R. (38) 95) Endopeptidase 22.19 Guillain-Barré syndrome Neuropeptide-metabolizing endopeptidase; Enkephalin; Experimental allergic neuritis; Ganglioside; Antibody Leukocyte; Neuroimmunomodulation (Paik, S.H. (38) 35) (Wiethdlter, H. (38) 221) 290 Homologous regulation Interleukin-3-like activity Vasoactive intestinal peptide (VIP); VIP receptor; Lympho- Peripheral benzodiazepine receptor; Mitogen-induced prolif- cyte; Compartmental kinetics; VIP receptor turnover (Otta- eration; Interleukin-2 (Bessler, H. (38) 19) way, C.A. (38) 241) Leukocyte Human immunodeficiency virus Endopeptidase 22.19; Neuropeptide-metabolizing endopepti- Cerebrospinal fluid; Leukotriene B, (Froldi, M. (38) 155) dase; Enkephalin; Neuroimmunomodulation (Paik, S.H. (38) 35) IGF-binding protein Insulin-like growth factor; Growth hormone; Proliferation; Leukocyte common antigen T-Lymphocyte; Mitogen (Kooijman, R. (38) 95) Experimental allergic encephalomyelitis; Interleukin-2 recep- tor; Flow cytometry; Central nervous system; Delayed-type Immune depression hypersensitivity (Jensen, M.A. (38) 255) Down’s syndrome; B-Adrenergic receptor; Flow cytometry; Cell sorter; Lymphocyte subset; T-helper; T-suppressor; Natu- Leukotriene B, ral killer (Morale, M.C. (38) 185) Human immunodeficiency virus; Cerebrospinal fluid (Froldi, M. (38) 155) Immune processing Proteolipid protein; T cell clones; Antigen-presenting cell Lymphocyte (Van der Veen, R.C. (38) 139) Alzheimer’s disease; Down’s syndrome; Actin (Jabbour, W. (38) 199) Imzaunoglobulin Vasoactive intestinal peptide (VIP); VIP receptor; Compart- Anti-neuronal antibodies; Synaptosome (Loeffler, D.A. (38) mental kinetics; VIP receptor turnover; Homologous regula- 45) tion (Ottaway, C.A. (38) 241) Immunological tolerance T-Lymphocyte Myasthenia gravis; Antigen-coupled syngeneic cell (McIntosh, Insulin-like growth factor; Growth hormone; IGF-binding K.R. (38) 75) protein; Proliferation; Mitogen (Kooijman, R. (38) 95) I dulation Lymphocyte subset B-Adrenergic receptor; Conditioned aversive stimulus Down’s syndrome; B-Adrenergic receptor; Immune depres- (Luecken, L.J. (38) 209) sion; Flow cytometry; Cell sorter; T-helper; T-suppressor; Natural killer (Morale, M.C. (38) 185) I pp ession Blood-brain barrier; Brequinar sodium; Cyclophosphamide; Macrophage Cyclosporin A; Experimental allergic encephalomyelitis Myelin phagocytosis; Complement receptor type 3; Tumor (O'Neill, J.K. (38) 53) necrosis factor alpha (TNF-a) (Briick, W. (38) 9) Insulin-like growth factor Measles virus Growth hormone; IGF-binding protein; Proliferation; T- T lymphocytes; Myelin associated glycoprotein; Multiple scle- Lymphocyte; Mitogen (Kooijman, R. (38) 95) rosis; Interferon-y (Link, H. (38) 63) Interferon-y Mitogen T lymphocytes; Measles virus; Myelin associated glycoprotein; Insulin-like growth factor; Growth hormone; IGF-binding Multiple sclerosis (Link, H. (38) 63) protein; Proliferation; T-Lymphocyte (Kooijman, R. (38) 95) Astrocyte; Complement; Astroglioma; C3 protein (Barnum, Mitogen-induced proliferation S.R. (38) 275) Peripheral benzodiazepine receptor; Interleukin-2; Inter- leukin-3-like activity (Bessler, H. (38) 19) Interleukin-2 Peripheral benzodiazepine receptor; Mitogen-induced prolif- Monocyte eration; Interleukin-3-like activity (Bessler, H. (38) 19) Anti-opiate peptide; F8Fa; T lymphocyte (Lecron, J.-C. (38) 1) Interleukin-2 receptor Experimental allergic encephalomyelitis; Leukocyte common Multiple sclerosis antigen; Flow cytometry; Central nervous system; Delayed- Cerebrospinal fluid; Tumor necrosis factor-a; Blood—brain type hypersensitivity (Jensen, M.A. (38) 255) barrier (Sharief, M.K. (38) 27) T lymphocytes; Measles virus; Myelin associated glycoprotein; Proliferation Interferon-y (Link, H. (38) 63) Insulin-like growth factor; Growth hormone; IGF-binding protein; T-Lymphocyte; Mitogen (Kooijman, R. (38) 95) Myelin basic protein; Myelin proteolipid protein; T cell fre- quency (Chou, Y.K. (38) 105) Proteolipid protein Immune processing; T cell clones; Antigen-presenting cell Retrovirus; Demyelination; Autoimmunity; Tropical spastic (Van der Veen, R.C. (38) 139) paraparesis; Myelopathy; (Conference abstracts) (Haahr, S. (38) 163) Experimental autoimmune encephalomyelitis; SJL/J mice; Encephalitogenic peptide (McRae, B.L. (38) 229) Myasthenia gravis Antigen-coupled syngeneic cell; Immunological tolerance Recombinant fusion protein (McIntosh, K.R. (38) 75) a-Bungarotoxin-binding protein; Nicotinic acetylcholine re- ceptor; Synthetic peptides; Avian nervous system; Epitope Myelin associated glycoprotein mapping (McLane, K.E. (38) 115) T lymphocytes; Measles virus; Multiple sclerosis; Interferon-y (Link, H. (38) 63) Retrovirus Multiple sclerosis; Demyelination; Autoimmunity; Tropical Myelin basic protein spastic paraparesis; Myelopathy; (Conference abstracts) Multiple sclerosis; Myelin proteolipid protein; T cell fre- (Haahr, S. (38) 163) quency (Chou, Y.K. (38) 105) SJL/J mice Myelin phagocytosis Experimental autoimmune encephalomyelitis; Proteolipid Macrophage; Complement receptor type 3; Tumor necrosis protein; Encephalitogenic peptide (McRae, B.L. (38) 229) factor alpha (TNF-a) (Briick, W. (38) 9) Synaptosome Myelin proteolipid protein Anti-neuronal antibodies; Immunoglobulin (Loeffler, D.A. Multiple sclerosis; Myelin basic protein; T cell frequency (38) 45) (Chou, Y.K. (38) 105) Synthetic peptides Myelopathy a-Bungarotoxin-binding protein; Nicotinic acetylcholine re- Multiple sclerosis; Retrovirus; Demyelination; Autoimmunity; ceptor; Recombinant fusion protein; Avian nervous system; Tropical spastic paraparesis; (Conference abstracts) (Haahr, Epitope mapping (McLane, K.E. (38) 115) S. (38) 163) T cell clones Natural killer Proteolipid protein; Immune processing; Antigen-presenting Down’s syndrome; B-Adrenergic receptor; Immune depres- cell (Van der Veen, R.C. (38) 139) sion; Flow cytometry; Cell sorter; Lymphocyte subset; T- helper; T-suppressor (Morale, M.C. (38) 185) T cell frequency Multiple sclerosis; Myelin basic protein; Myelin proteolipid NN,e ur . Anil e ion protein (Chou, Y.K. (38) 105) Endopeptidase 22.19; Neuropeptide-metabolizing endopepti- dase; Enkephalin; Leukocyte (Paik, $.H. (38) 35) T cell proliferation Accessory function; Glioma cells (Yamada, M. (38) 263) Neuronal systemic lupus erythematosus Antibody; Brain elution (Moore, P.M. (38) 147) T-helper Down’s syndrome; B-Adrenergic receptor; Immune depres- Neuropeptide-metabolizing endopeptidase sion; Flow cytometry; Cell sorter; Lymphocyte subset; T-sup- Endopeptidase 22.19; Enkephalin; Leukocyte; Neuroim- pressor; Natural killer (Morale, M.C. (38) 185) munomodulation (Paik, S.H. (38) 35) T lymphocyte Nicotinic acetylcholine receptor Anti-opiate peptide; F8Fa; Monocyte (Lecron, J.-C. (38) 1) a-Bungarotoxin-binding protein; Synthetic peptides; Recom- binant fusion protein; Avian nervous system; Epitope map- Measles virus; Myelin associated glycoprotein; Multiple scle- ping (McLane, K.E. (38) 115) rosis; Interferon-y (Link, H. (38) 63) Peripheral benzodiazepine receptor Tropical spastic paraparesis Mitogen-induced proliferation; Interleukin-2; Interleukin-3- Multiple sclerosis; Retrovirus; Demyelination; Autoimmunity; like activity (Bessler, H. (38) 19) Myelopathy; (Conference abstracts) (Haahr, S. (38) 163) 292 T-suppressor VIP receptor Down’s syndrome; B-Adrenergic receptor; Immune depres- Vasoactive intestinal peptide (VIP); Lymphocyte; Compart- sion; Flow cytometry; Cell sorter; Lymphocyte subset; T- mental kinetics; VIP receptor turnover; Homologous regula- helper; Natural killer (Morale, M.C. (38) 185) tion (Ottaway, C.A. (38) 241) Tumor necrosis factor-a Myelin phagocytosis; Macrophage; Complement receptor type 3 (Briick, W. (38) 9) VIP receptor turnover Cerebrospinal fluid; Multiple sclerosis; Blood—brain barrier Vasoactive intestinal peptide (VIP); VIP receptor; Lympho- (Sharief, M.K. (38) 27) cyte; Compartmental kinetics; Homologous regulation (Otta- way, C.A. (38) 241) Vasoactive intestinal peptide (VIP) VIP receptor; Lymphocyte; Compartmental kinetics; VIP re- ceptor turnover; Homologous regulation (Ottaway, C.A. (38) 241) {}% . ‘